This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.bbc.co.uk/news/51980731

The article has changed 32 times. There is an RSS feed of changes available.

Version 22 Version 23
Coronavirus and hydroxychloroquine: What do we know? Coronavirus and hydroxychloroquine: What do we know?
(1 day later)
Drugs normally used to treat malaria, hydroxychloroquine and chloroquine, have been touted as potential treatments for coronavirus. There's a lot of interest in using hydroxychloroquine and chloroquine as potential treatments for coronavirus.
The treatments have been promoted and used by some world leaders, but concerns have been raised about their safety and efficacy. The drugs - normally used for malaria and other conditions - have been promoted and used by some world leaders, despite concerns about their safety and efficacy.
We've looked at what we know so far about these drugs.We've looked at what we know so far about these drugs.
Why have these drugs gained prominence?Why have these drugs gained prominence?
US President Donald Trump revealed in May that he was taking hydroxychloroquine as a preventative measure against Covid-19, but later said he'd stopped.US President Donald Trump revealed in May that he was taking hydroxychloroquine as a preventative measure against Covid-19, but later said he'd stopped.
Mr Trump has repeatedly referred to its potential. At a press conference in April, he said: "What do you have to lose? Take it."Mr Trump has repeatedly referred to its potential. At a press conference in April, he said: "What do you have to lose? Take it."
Following Mr Trump's comments, there was a sharp increase reported in prescriptions in the US for both hydroxychloroquine and the related drug, chloroquine.Following Mr Trump's comments, there was a sharp increase reported in prescriptions in the US for both hydroxychloroquine and the related drug, chloroquine.
Brazilian President Jair Bolsonaro claimed in a video that "hydroxychloroquine is working in all places." This was removed by Facebook for breaching its misinformation guidelines.Brazilian President Jair Bolsonaro claimed in a video that "hydroxychloroquine is working in all places." This was removed by Facebook for breaching its misinformation guidelines.
There's also been a global surge in demand for them.There's also been a global surge in demand for them.
What are the concerns about safety?What are the concerns about safety?
There is concern in the scientific community about using such drugs to treat coronavirus.
Hydroxychloroquine is safe for treating malaria, and conditions like lupus or arthritis, but so far no clinical trials have recommended it for use against Covid-19.Hydroxychloroquine is safe for treating malaria, and conditions like lupus or arthritis, but so far no clinical trials have recommended it for use against Covid-19.
Safety fears were highlighted following research published in the Lancet medical journal that reviewed the medical records of thousands of coronavirus patients. Safety fears were highlighted following an article in the Lancet medical journal in May which said the drugs could increase the risk of heart problems.
This suggested there were no benefits to taking the drugs - and they could even increase the risk of heart problems. But the Lancet has now retracted this because of issues around the data that was used for the research.
But the Lancet has now put out "an expression of concern" about the research after questions about the data that was used by a group of scientists. And the World Health Organization (WHO) said on 3 June it was resuming trials involving hydroxychloroquine, which it had earlier suspended over safety concerns.
The World Health Organization (WHO), which had halted some trials using hydroxychloroquine because of these safety concerns, announced on 3 June that it would resume them.
Is there evidence they work against Covid-19?Is there evidence they work against Covid-19?
There are trials in various countries on using the drugs to prevent the illness, sometimes involving frontline workers taking it as a prophylactic.
A trial is underway across Europe, Africa, Asia and South America, testing 40,000 people with either hydroxychloroquine, chloroquine or a placebo to see if it's effective in preventing the virus.
Other studies are looking into whether it can help patients who already have Covid-19.
In the US, various trials are taking place for a combination of drugs including chloroquine, hydroxychloroquine and an antibiotic called azithromycin, for treating Covid-19 patients.
Nigeria has said it will continue with its own planned clinical trials.
The country's drugs approval agency said it does not dispute the WHO's safety warnings, but wanted to generate data from tests on the local population.
Morocco, Algeria and Senegal have also decided to continue trials, although Kenya says it will be suspending its planned studies.
At the moment, there's not a great deal of evidence to show whether or not they're effective for either prevention or treatment.At the moment, there's not a great deal of evidence to show whether or not they're effective for either prevention or treatment.
There are trials in various countries on using the drugs to prevent Covid-19, sometimes involving frontline workers who are more likely to be exposed to the virus.
A trial is underway across Europe, Africa, Asia and South America, testing 40,000 people with either hydroxychloroquine, chloroquine or a placebo (a dummy drug used as a control in the test) to see if it's effective.
In the US, various trials are taking place for a combination of drugs including chloroquine, hydroxychloroquine and an antibiotic called azithromycin, for treating patients who already have Covid-19.
Nigeria is conducting trials, as are Morocco, Algeria and Senegal. However, Kenya suspended its trials in the wake of safety concerns.
Results that have come out from one clinical trial of hydroxychloroquine by the University of Minnesota in the US show it is not effective at preventing Covid-19.Results that have come out from one clinical trial of hydroxychloroquine by the University of Minnesota in the US show it is not effective at preventing Covid-19.
Over 800 US and Canadian health care workers and other individuals exposed to the virus were given either a placebo or the drug. No significant difference was found in the percentages of each group who got Covid-19. Over 800 US and Canadian health care workers and other individuals exposed to the virus were given either a placebo or the drug.
No significant difference was found in the percentages of each group who got Covid-19.
Are any countries already using these drugs?Are any countries already using these drugs?
There are countries using the drugs, usually in specific circumstances.
In late March, the US Food and Drugs Administration (FDA) granted "emergency use" authorisation for these drugs in the treatment of Covid-19 for a limited number of hospitalised cases.In late March, the US Food and Drugs Administration (FDA) granted "emergency use" authorisation for these drugs in the treatment of Covid-19 for a limited number of hospitalised cases.
That means that in specific circumstances only, hospitals can request and use the medicines for Covid-19 treatment. That means that hospitals can request and use the medicines for Covid-19 treatment under certain conditions.
But on 24 April, the FDA issued a warning about the dangers of using the substances because of reports of heart rhythm problems in patients.But on 24 April, the FDA issued a warning about the dangers of using the substances because of reports of heart rhythm problems in patients.
Other countries also deploying these drugs in various settings. And France, which had authorised hospitals to prescribe the drugs for patients with Covid-19, later reversed the decision after the country's medical watchdog warned of possible side effects.
Brazil has relaxed its restrictions to allow doctors to prescribe them to patients with mild coronavirus symptoms, not just those in a serious condition in hospital. However, Brazil has relaxed its restrictions to allow doctors to prescribe hydroxychloroquine to patients with mild coronavirus symptoms, not just those in a serious condition in hospital.
And the US government has sent two million doses to Brazil for frontline workers and those receiving treatment in hospitals. The US government has sent two million doses to Brazil for frontline workers and those receiving treatment in hospitals.
The Indian government has expanded the use of the drug as a preventative medicine - but only under medical supervision - for healthcare workers in non-coronavirus environments, and police working in areas with high rates of Covid-19. The Indian government expanded the use of the drug as a preventative medicine - but only under medical supervision - for healthcare workers in non-coronavirus environments, and for police working in areas with high rates of Covid-19.
France, which had authorised hospitals to prescribe them for patients with Covid-19, later reversed the decision after the country's medical watchdog warned of side effects.
Read more from Reality CheckRead more from Reality Check
Send us your questionsSend us your questions
Follow us on TwitterFollow us on Twitter